Agenda item: 9.4 Subject: Individual Funding Review (IFR) Policies:   Continuous Glucose Monitoring Functional Electronic Stimulation Presented by: Dr Shamsher Diu, Consultant in Public Health Submitted to: Governing Body Date: 4 November 2014 Purpose of paper: Approval of policies Executive Summary: Two new policies are presented for the Governing Body’s consideration. These policies were developed as a result of a number of applications to the Norfolk & Waveney NonDrugs IFR Panel. The overarching IFR Policy states that once the Panel receives three applications or more for a particular procedure, then a policy needs to be developed. All of these policies have been discussed with CCG representatives on the IFR Panel’s Clinical Policy Development Group and have involved clinicians from provider Trusts. The polices relate to:   Continuous Glucose Monitoring Functional Electronic Stimulation These policies are to ensure that patients receive the most appropriate and effective treatments for a range of medical conditions which are not routinely offered. They also ensure that NHS funds are used appropriately. Recommendation to Governing Body: The Governing Body is asked to approve the attached policies. Key Risks Clinical: Finance and Performance: The policies ensure patients receive the most appropriate and effective treatments. N/A Impact Assessment (environmental and equalities): N/A Reputation: Legal: Resource Required: It is important to the reputation of the CCG that clear policies are in place None See attached policies Reference document(s): See attached policies. GOVERNANCE Process/Committee approval with date(s) (as appropriate) Leadership Team on 21.10.14